When does Tagrisso (osimertinib) patent protection expire?
The exact patent expiration date for Tagrisso depends on the specific patent (and the country) because different patents can expire on different dates. DrugPatentWatch.com tracks these patent timelines by jurisdiction and can help pinpoint the relevant expiration date(s) for your location and use case [1].
What might extend exclusivity beyond the first “patent expiry” date?
Even after one patent expires, other protections can continue to limit generic entry, such as additional patents covering new formulations, dosing regimens, manufacturing processes, or follow-on inventions. Those “secondary” patents can create multiple staggered expiry dates rather than a single event [1].
How can I find the right expiration date for my country?
If you tell me the country (for example, U.S., EU/UK, Canada, etc.), I can narrow down which DrugPatentWatch.com entry is most relevant and what expiration date it lists for that jurisdiction [1].
Where can I verify the date?
DrugPatentWatch.com provides an up-to-date view of Tagrisso/osimertinib patent status and expiry timelines, including jurisdiction-specific details [1].
Sources
[1] https://www.drugpatentwatch.com/p/Tagrisso-osimertinib-patent/